Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
about
Ten years of tiotropium: clinical impact and patient perspectivesManaging comorbidities in COPDPrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysisTiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials.Copd.Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 updateDoes tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysisAn integrative review of systematic reviews related to the management of breathlessness in respiratory illnessesRisk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review.Risks associated with tiotropium in chronic obstructive pulmonary disease: overview of the evidence to date.Inhaled anticholinergic drugs and risk of acute urinary retention.Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary diseaseInformation for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice.Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population--a population based cohort study.Chronic obstructive pulmonary disease hospital admissions and drugs--unexpected positive associations: a retrospective general practice cohort studyPalliative care provision for patients with chronic obstructive pulmonary disease.Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.How effective are common medications: a perspective based on meta-analyses of major drugs.Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling studyComparative efficacy of indacaterol in chronic obstructive pulmonary disease.Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patientsPersonalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.Airway disease: similarities and differences between asthma, COPD and bronchiectasis.Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan PopulationOptimizing safety of COPD treatments: role of the nurse practitioner.Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena.Differentiating COPD from asthma in clinical practice.Role of tiotropium in the treatment of COPD.Safety, tolerability and risk benefit analysis of tiotropium in COPD.Treatment of mild chronic obstructive pulmonary disease.Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE studyComorbidities, patient knowledge, and disease management in a national sample of patients with COPD.In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.Exacerbation rate, health status and mortality in COPD--a review of potential interventionsLong-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.Targeted treatment in COPD: a multi-system approach for a multi-system disease.
P2860
Q26823682-C3C337D1-0999-4893-B0D1-8A52FC6F166DQ27005858-CC8E31A9-944E-434B-98A7-1D2025895F53Q27348844-FAABCADF-6D37-44D9-83BC-57A1E734D535Q28258219-177C56E9-BAC2-4CC2-B2D3-0CDD23B0FA5EQ30620671-E9E2FD4B-44D8-4868-AD4B-633D5D136ACFQ30877371-8704675B-CBE3-41A7-9914-D35EBB0BBE44Q31016356-9CDF33A9-78D1-4120-B081-98C884F9ADACQ33591899-B8D5D205-DC93-4CA8-A436-944F78662F45Q33698524-0C707BF4-EA35-4ACD-B4AD-617FF474ABA3Q33766956-1EDAC266-558F-4D5A-95CF-998D8C86AC9FQ33949299-805704E0-28BC-4653-9D0C-3C68600A9E64Q33949317-1B1A9932-775D-4C90-A6EA-4CA1BA17D7EEQ34024144-CB801DD7-8EE7-4E9F-9F13-0AC37EBECA9EQ34995066-B40F133A-58DF-4837-9B7E-C83016EE1653Q35057288-8AB4C65D-5381-46E4-B937-F530EF9C0971Q35097000-4F1215EE-A223-4DA0-9F7F-E7B1E2EBEDD4Q35128794-25ED2CCC-0EF9-4285-98F7-86ABF88BEAEDQ35215962-5928D263-0A05-425D-9DC1-FF65A5133DB1Q35750714-4FDA3A67-7377-4844-A8E8-6A24CD723FF0Q35762406-86F8D412-7780-41DE-BF57-69861F5DD1C2Q35797656-55CE7C8B-1E20-447F-9B94-380A4EEB2585Q35798055-5567B9BD-D3CC-47DB-A88B-196157A12A8FQ35822146-D499B7CE-C8C7-45FA-9707-31EB4BFCF127Q35971002-23BC169F-547E-433B-BE7A-6A93F80E7ABCQ36037006-13EC9542-D9CE-4ABF-844A-E99322128691Q36371261-1CAECAA5-4F6A-4514-BE21-F3B48B767E9DQ36421017-2BA513FF-3FAC-4944-A19C-C757BD95D7E4Q36642198-2CE57F00-CC0A-4354-951B-38BAAB851474Q36742804-A94C3EDA-747F-4752-932A-A2020E58670BQ36951507-C7C3FA47-FE14-4809-BC24-FD1145668545Q37017516-1F74864E-2ED3-4EBE-BE02-F6647710CC12Q37115876-03750B6E-DFEC-4206-9D4C-225063AA1AFEQ37115902-7B13A7BD-2131-4423-A7E8-2F56B933A059Q37181446-3433065D-AC52-4218-B4F4-1128DA62F191Q37217701-FDC78C3E-7EC6-4C44-A49B-E35F0BD08BB4Q37230811-E66F037A-9246-4346-A2B5-52A77FCE2F69Q37231865-C97C0B86-6D44-4954-BEDF-5CB100481D89Q37236165-D7117B0C-FBB1-4BC6-8018-50C32C2BFDF7Q37310689-D9B80E05-3E54-467D-8B83-EAF5EEAD52E6Q37340178-710162B3-9359-493D-A891-18EBF9B2AFE1
P2860
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
@ast
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
@en
type
label
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
@ast
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
@en
prefLabel
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
@ast
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
@en
P2093
P2860
P356
P1433
P1476
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
@en
P2093
P2860
P304
P356
10.1136/THX.2006.063271
P407
P577
2006-07-14T00:00:00Z